top of page

GENOS IMMUNE PLUS SYSTEMIC REBALANCING

GENOS Immune Plus for Autoimmune Diseases

Restoring Immune Balance – Without Immunosuppression

GENOS Immune Plus restores immune balance in auto-immune diseases by targeting the root cause: dysregulated immune network control—not isolated immune activity.

Autoimmune diseases are not caused by isolated overactivity, but by a loss of coordinated immune control across multiple regulatory axes.

GENOS Immune Plus therefore does not follow a traditional immunosuppressive or nonspecific stimulatory approach, but rather a systems biology model of functional immune rebalancing. The focus is on restoring a physiological, regulated immune response.

A New Therapeutic Principle

  • no conventional immunosuppression 

  • no nonspecific immune stimulation 

  • but targeted functional immune rebalancing

The objective is the restoration of a physiological, self-regulated immune response.

Clinical and immunological follow-up observations show a consistent pattern: GENOS Immune Plus does not act as an isolated intervention in individual signaling pathways, but rather as a functional network modulator of the immune system.

  • Stabilization of key immune axes

  • Reduction of dysregulated antibody responses

  • Improvement of immunological control

  • Normalization of cell distribution and inflammatory dynamics

tab-8.png
What Happens in Autoimmunity

Autoimmune disorders are characterized by a breakdown of immune coordination:

  • imbalance of CD4⁺ / CD8⁺ T cells 

  • shift in TH1 / TH2 signaling 

  • overproduction of autoantibodies (e.g., ANA) 

  • dysregulated immune cell migration 

  • persistent inflammatory activation 

The problem is not one pathway—but the system as a whole.

The therapeutic approach of GENOS Immune Plus addresses the root cause—not the individual immune response, but the dysfunction of the immune system as a whole. A stable immune system is characterized by functional balance, controlled cell distribution, and regulated antibody production

tab-9.png

1. TH1 / TH2 Rebalancing
Restoration of Cytokine-Guided Immune Balance

In autoimmune conditions, the immune response is frequently TH2-dominant, promoting B-cell activation and autoantibody production. As illustrated in the graphic, GENOS Immune Plus is associated with a shift toward a balanced TH1/TH2 profile, supporting:

  • normalization of IL-4 ↔ IFN-γ signaling 

  • improved regulation of immune responses 

  • reduction of chronic inflammatory activity 

Result: restored cytokine balance and improved immune tolerance

2. CD4 / CD8 Rebalancing
Restoration of Adaptive Immune Control

A markedly elevated CD4/CD8 ratio reflects loss of cytotoxic control and immune regulation. As illustrated in the graphic, GENOS Immune Plus is associated with normalization of this axis, leading to:

  • restored balance between helper and cytotoxic T cells 

  • improved immune control and resolution capacity 

  • reduced chronic immune activation 

Result: re-established adaptive immune coordination

3. S1P Axis Regulation
Controlled Immune Cell Migration

The S1P axis regulates where immune responses take place by controlling lymphocyte trafficking. In autoimmunity, dysregulation leads to excessive tissue infiltration and persistent inflammation.

As illustrated in the graphic, GENOS Immune Plus is associated with:

  • improved immune cell distribution 

  • controlled tissue infiltration 

  • restoration of regulatory feedback 

Result: reduced tissue inflammation and stabilized immune dynamics

4. B-Cell Activity & Autoantibody Regulation
Restoration of Humoral Immune Balance

Autoimmune processes are driven by activation of autoreactive B cells and autoantibody production. As illustrated in the graphic, GENOS Immune Plus supports normalization by:

  • rect modulation of B-cell activity via T-cell regulation 

  • of autoantibody responses 

  • stabilization of humoral immunity 

Result: reduced autoimmune reactivity and improved immune regulation

System-Level Effect

GENOS Immune Plus does not act on a single receptor or pathway. It restores the coordination of immune networks at a system level—re-establishing functional communication between immune cells, signaling pathways, and regulatory mechanisms.

  • cytokine signaling 

  • cellular immunity 

  • humoral immunity 

  • immune cell migration 

Clinical Impact

  • reduction of disease-related inflammation 

  • improved immune regulation 

  • stabilization of chronic autoimmune activity 

  • support of long-term immune resilience

Complementary Approach

  • Further information is available upon request. In selected cases, GENOS Annexin11, the membrane- and cell-stabilizing, anti-inflammatory magistral recipe may be used as a complementary therapeutic component. Detailed data are available upon request. Please contact our Support Team, Ms. Schulz.

GENOS Immune Plus does not suppress the immune system. It restores its ability to regulate itself.

Scientific & Regulatory Notice

The presented content is intended for scientific and educational purposes. Illustrations and graphical representations include schematic and illustrative elements and are not derived from individual patient data. The described effects are based on clinical observations and functional immunological assessments. This information does not replace individual medical evaluation or treatment decisions.

bottom of page